Bio
Dr. Matthew Reeves is the Executive Director and founder of the DuPont Clinic, a center providing patient-centered abortion care in all trimesters. With the team at the DuPont Clinic, Dr. Reeves has worked to re-envision the patient experience, create a new patient flow without a waiting room, develop new shortened protocols for later abortion, improve nurse-administered moderate sedation techniques, and introduce new and redesigned gynecologic instruments. Dr. Reeves also serves on the board of directors of DKT International, a social marketing organization that provided over 44 million couple-years of contraception in over 25 countries and is now the sole distributor for Ipas aspirators and Sino-Implant II. Previously, he was Medical Director of the National Abortion Federation where he worked to improve the quality of abortion care across North and South America. From 2010-2014, Dr. Reeves was the Chief Medical Officer of WomanCare Global where his work focused on expanding use of manual uterine aspiration and introducing mifepristone and levonorgestrel implants to new markets. Throughout his career, Dr. Reeves has worked on clinical research, primarily in the areas of post-abortal intrauterine contraception and improvements in abortion service delivery. In addition to this appointment at Stanford, he currently has an appointment as an Adjunct Associate Professor at the Johns Hopkins Bloomberg School of Public Health. Dr. Reeves attended Harvard Medical School and completed residency in obstetrics & gynecology at the University of California, San Francisco (UCSF). He then completed the fellowship in Clinical Ultrasound at UCSF followed by the Fellowship in Family Planning at the University of Pittsburgh.
